Thursday, June 13, 2024
HomeMedicineCardiologyUsing epinephrine in cardiac arrest comes at a cost  

Using epinephrine in cardiac arrest comes at a cost  

A clinical trial published in the NEJM sought to determine if epinephrine is a safe and effective drug to use during a cardiac arrest.

Emergency workers have few options in their arsenal to use on people suffering a cardiac arrest. Whilst CPR and prompt defibrillation have been clearly proven to be effective, many other treatment options have not been proven to be safe or effective.

Conflicting evidence on the use of epinephrine in cardiac arrest

Epinephrine, also known as adrenaline, is one such drug where there is conflicting evidence regarding its safety and usefulness in cardiac arrest. Epinephrine, which occurs naturally in the body, can help increase blood pressure and improve blood flow to the heart. When given in larger doses during a cardiac arrest it can allow the heart to start beating again.

So, why, is there conflict regarding a drug that may save your life? Research up until now has suggested that patients who are given epinephrine in cardiac arrest may be left with significant brain damage. To gain better quality information for decision-making, the International Liason Committee on Resuscitation called for a clinical trial to determine if epinephrine in cardiac arrest is safe and effective.

The results of the clinical trial, based in the United Kingdom, were recently published in the New England Journal of Medicine. Researchers included only patients who had a cardiac arrest outside of the hospital setting in the study.

Paramedics attending the cardiac arrest were given a package by researchers to use if CPR and the defibrillator had not worked. It included a syringe of epinephrine or a syringe of a salt-water solution (placebo solution which would not help in any way). The paramedics did not know which syringe they had. But once the paramedics entered a serial code into a database, researchers could track the outcome of the cardiac arrest. This ‘blinding’ of the paramedics helped eliminate any bias that has affected the results of previous trials.

A total of 8014 patients who had cardiac arrest were included in the clinical trial, over a period of three years. Due to the emergent nature of cardiac arrest, consent could not be obtained from patients ahead of time.

Survival via epinephrine may come at the cost of brain damage

The results showed that patients who received epinephrine were more likely to be alive 30 days after the cardiac arrest than those who did not. However, for many patients, survival came at the cost of brain damage. More patients in the group who received epinephrine suffered from brain damage than those who received the placebo solution.

Due to the high-quality evidence from this clinical trial, a dilemma is raised. Is it better to give epinephrine and be alive at all costs, even if that includes brain damage? The researchers discuss that previous research on this subject has indicated that the public and patients feel that survival with good brain function is more important than simply surviving.

The researchers discuss that the value of epinephrine in improving outcome from cardiac arrest pales in comparison to the difference that CPR or use of a defibrillator makes. But they do not make a recommendation on whether epinephrine should be used or not. That difficult decision is one for the policymakers.

Written by Nicola Cribb, VetMB DVSc Dip.ACVS

Reference: Perkins G, Ji C, Deakin C, et al. A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest. New Engl J Med. 2018. doi:10.1056/NEJMoa1806842.

Nicola Cribb
Nicola Cribb
Nicola obtained her Veterinary and Master’s degrees from the University of Cambridge, UK, and Doctor of Veterinary Science from the University of Guelph, Canada. She is board-certified in surgery and has research interests in minimally-invasive surgery. She has worked in a clinical setting, as well as research and teaching disciplines for the past 16 years at the University of Guelph, where she is currently Adjunct Faculty. She is a freelance medical writer and reviews, authors, and co-authors publications and reviews in scientific journals and books.
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News and Articles

SUBSCRIBE TO OUR NEWSLETTERS

Stay Connected
10,288FansLike
820FollowersFollow
249FollowersFollow
2,787FollowersFollow

Article of the month

Vitamin D as an Anti Colorectal Cancer Agent in 2024 – a Review of the Evidence

Vitamin D has a protective effect against colorectal cancer, but it is patient and population dependent.According to the WHO, colorectal cancer (CRC) is the...

Joke Of The Day- June 13

After 20 hours in delivery, a woman changes her mind and decides to go home. Doctor: This is the first time I have seen a...

ADVERTISE WITH US

error: Content is read-only and copy-protected.